Berlin - Delayed Quote EUR

Adaptimmune Therapeutics PLC (473A.BE)

0.2400
-0.0020
(-0.83%)
At close: May 30 at 5:20:06 PM GMT+2
Loading Chart for 473A.BE
  • Previous Close 0.2420
  • Open 0.2400
  • Bid 0.2240 x --
  • Ask 0.2800 x --
  • Day's Range 0.2340 - 0.2440
  • 52 Week Range 0.1820 - 1.3400
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 473A.BE

Mehr anzeigen

Performance Overview: 473A.BE

Trailing total returns as of 6/1/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

473A.BE
58.26%
MSCI WORLD (^990100-USD-STRD)
4.20%

1-Year Return

473A.BE
76.92%
MSCI WORLD (^990100-USD-STRD)
12.14%

3-Year Return

473A.BE
82.35%
MSCI WORLD (^990100-USD-STRD)
39.46%

5-Year Return

473A.BE
97.60%
MSCI WORLD (^990100-USD-STRD)
78.54%

Vergleichen mit: 473A.BE

Auswählen, um ähnliche Unternehmen anhand wichtiger Performance-Metriken zu analysieren; bis zu 4 Aktien auswählen.

Statistics: 473A.BE

Mehr anzeigen

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    67.19M

  • Enterprise Value

    57.65M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.39

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.37

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 473A.BE

Mehr anzeigen

Company Insights: 473A.BE

Research-Reports: 473A.BE

Mehr anzeigen